Cystatin C: current position and future prospects

Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD

(2008) Lesley A. Stevens et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

New Data on the Intraindividual Variation of Cystatin C

(2008) Pierre Delanaye et al.   NEPHRON CLINICAL PRACTICE

Kidney dysfunction and fatal cardiovascular disease—an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study

(2007) Rajat Deo et al.   AMERICAN HEART JOURNAL

Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate

(2007) Giampaolo Niccoli et al.   ATHEROSCLEROSIS

Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications

(2007) Francesca M. Tumminello et al.   BIOMEDICINE & PHARMACOTHERAPY

Beta-trace protein is not superior to cystatin C for the estimation of GFR in patients receiving corticosteroids

(2007) Floor C.H. Abbink et al.   CLINICAL BIOCHEMISTRY

Serum cystatin C in diabetic patients

(2007) Yoshiji Ogawa et al.   DIABETES RESEARCH AND CLINICAL PRACTICE